219 related articles for article (PubMed ID: 24735543)
1. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
2. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
4. MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.
Feng S; Pan W; Jin Y; Zheng J
Tumour Biol; 2014 Dec; 35(12):12339-44. PubMed ID: 25179841
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
Qin W; Ren Q; Liu T; Huang Y; Wang J
FEBS Lett; 2013 May; 587(9):1434-9. PubMed ID: 23523916
[TBL] [Abstract][Full Text] [Related]
7. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.
Yang X; Yu J; Yin J; Xiang Q; Tang H; Lei X
Pharmazie; 2012 Jul; 67(7):645-51. PubMed ID: 22888524
[TBL] [Abstract][Full Text] [Related]
8. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
Wu H; Xiao Z; Wang K; Liu W; Hao Q
Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
[TBL] [Abstract][Full Text] [Related]
9. MiR-718 represses VEGF and inhibits ovarian cancer cell progression.
Leng R; Zha L; Tang L
FEBS Lett; 2014 Jun; 588(12):2078-86. PubMed ID: 24815691
[TBL] [Abstract][Full Text] [Related]
10. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
[TBL] [Abstract][Full Text] [Related]
11. MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.
Zhi F; Wang Q; Deng D; Shao N; Wang R; Xue L; Wang S; Xia X; Yang Y
PLoS One; 2014; 9(10):e109124. PubMed ID: 25299073
[TBL] [Abstract][Full Text] [Related]
12. miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.
Yang L; Wang YL; Liu S; Zhang PP; Chen Z; Liu M; Tang H
FEBS Lett; 2014 Jan; 588(1):124-30. PubMed ID: 24269684
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.
Zhou J; Xie M; Shi Y; Luo B; Gong G; Li J; Wang J; Zhao W; Zi Y; Wu X; Wen J
Oncol Rep; 2015 Jul; 34(1):111-20. PubMed ID: 25954928
[TBL] [Abstract][Full Text] [Related]
14. MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression.
Ying X; Li-ya Q; Feng Z; Yin W; Ji-hong L
Biomed Pharmacother; 2015 Apr; 71():64-9. PubMed ID: 25960217
[TBL] [Abstract][Full Text] [Related]
15. MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.
Liu R; Liu F; Li L; Sun M; Chen K
Biomed Pharmacother; 2015 May; 72():52-7. PubMed ID: 26054675
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
[TBL] [Abstract][Full Text] [Related]
17. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
[TBL] [Abstract][Full Text] [Related]
18. miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells.
Zhang M; Wang X; Li W; Cui Y
Biochem Biophys Res Commun; 2015 May; 460(3):806-12. PubMed ID: 25824045
[TBL] [Abstract][Full Text] [Related]
19. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
